[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2019 Future Horizons and Growth Strategies in the French Blood Banking Market: Supplier Shares and Country Forecasts

August 2015 | 430 pages | ID: 2340801F9CFEN
Venture Planning Group

US$ 4,880.00 US$ 6,100.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
"2015-2019 Future Horizons and Growth Strategies in the French Blood Banking Market" is a new strategic analysis prepared by VPGMarketResearch in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business, new product development and marketing strategies.
I. INTRODUCTION

II. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

A. Major Blood Typing, Grouping and Infectious Disease Screening Tests
  1. Blood Typing and Grouping Tests
    a. ABO
    b. Antibody Panels
    c. Antibody Screening
    d. Antigen Typing
    e. Antiglobulin Test
    f. Crossmatch
    g. HLA Typing
    h. Rh
    i. Other Blood Groups
  2. Blood Group Genotyping
    a. PCR
    b. PCR-RFLP
    c. AS-PCR or PCR-SSP
    d. Multiplex PCR
    e. Real Time PCR
    f. Sanger DNA Sequencing
    g. Pyrosequencing
    b. Microarrays
      BeadChip Array
      BloodChip
      Genome Lab SNP Stream
      Fluidic Microarray Systems
      TaqMan OpenArray
      MALDI-TOF-MS
      Mini-Sequencing
  3. Infectious Disease Screening Tests
    a. AIDS
      Structure and Composition
      Classification
      Origin of AIDS
      Animal Lentivirus Systems
      Virus Receptors
      HIV Infections in Humans
        Pathogenesis & Pathology
        Overview of Course of HIV Infection
      CD4T Lymphocytes and Memory Cells
      Monocytes and Macrophages
      Lymphoid Organs
      Neural Cells
      Viral Coinfections
        Clinical Findings
      Plasma Viral Load
      Pediactric AIDS
        Neurologic Disease
        Opportunistic Infections
        Protozoa
        Fungi
        Bacteria
      Viruses
      Cancer
      Immunity
      Laboratory Diagnosis
        Virus Isolation
        Serology
        Detection of Viral Nucleic Acid or Antigens
      Epidemiology
        Worldwide Spread of AIDS
        United States
        Routes of Transmission
      Prevention, Treatment, And Control
        Antiviral Drugs
        Vaccines Against HIV
      Transmission of HIV in Blood Products
      HIV Transmission in Transplant and Artificial Insemination Recipients
      Diagnostic Tests
      Enzyme Immunoassay Interpretation
      Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
      Competition Assays
      Western Blot Technique
      Immuno-Fluorescence Assay (IFA)
      Radioimmunoprecipitation
      HIV-1/HIV-2 Combination Testing
      Methods of HIV-Antigen Detection
      Antigen Assays and Blood Screening
      Urine Tests
      DNA Probes
      Overview
      Quantitative Polymerase Chain Reaction
      In Situ PCR
      Needed Improvements
      Viral Load/Drug Resistance Testing
      Genotype and Phenotype Testing
      Blood Banking Considerations
    b. Hepatitis
      Hepatitis A
      Hepatitis B
        Structure and Composition
        Replication of Hepatitis B Virus
      Hepatitis C
      Hepatitis D (Delta Hepatitis)
      Hepatitis E
      Hepatitis G
      Hepatitis Virus Infections In Humans
        Pathology
      Clinical Findings
      Laboratory Features
        Hepatitis A
        Hepatitis B
        Hepatitis C
        Hepatitis D
        Hepatitis E
      Virus-Host Immune Reactions
      Epidemiology
        Hepatitis A
        Hepatitis B
        Hepatitis C
        Hepatitis D (Delta Agent)
      Vaccines and Drugs
    c. Cytomegalovirus
      Background
      Chorioretinitis
      Gastrointestinal
      Central Nervous System Disease
      Diagnostic Tests
      Vaccines and Drugs
    d. Syphilis
      Background
      Diagnostic Tests
      Vaccines and Drugs
    e. West Nile Virus
      Background
      Clinical Syndromes
      Diagnostic Tests
      Vaccines and Drugs
    f. Parvovirus B19
      Microbiology
      Epidemiology
      Clinical Syndromes
        Erythema Infectiosum Slapped (cheek)
        Adult Polyarthropathy
        Transient Aplastic Crisis
        Transient Pancytopenia
        Red Cell Aplasia in the Immunocompromised
        Perinatal Infections
      Diagnosis
      Treatment
    g. Creutzfeldt-Jakob’s Disease
      Background
      Transmission
      Diagnostic Tests
      Major Commercial and Academic Players
        Bayer
        Disease Sciences/BioTec Global
        Imperial College School of Medicine
        Ortho-Clinical Diagnostics
        Pall
        ProMetic Life Sciences
        Proteome Sciences/Idexx
        Q-One Biotech
        Serono
        U.S. Agricultural Research Service
      Drugs
      Vaccines
    h. Malaria
    i. Chagas Disease
    j. Babesiosis
  4. Pathogen Reduction
  5. Leukocyte Reduction
    Background
    Methods
B. Instrumentation Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
  Abbott
  Beckman Coulter/Danaher
  Becton Dickinson
  Bio-Rad
  BioMerieux
  Cepheid
  Curtis Unyvero
  Gen-Probe/Hologic
  GenMark
  Grifols
  HTG
  Immucor
  Life Technologies
  Nanosphere
  Ortho-Clinical Diagnostics
  Qiagen
  Roche
  Sarstedt
  Siemens
  Tecan
C. Major in Vitro Diagnostic Technologies And Their Potential Applications
  1. Molecular Diagnostics
    a. Overview
    b. NAT
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Technological Principle
    b. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
  4. Microtitration Plates
  5. IT and Automation
  6. Lasers
  7. Robotics
  8. Synthetic Red Cell Substitutes
  9. Genetically Engineered Blood Components
    a. Albumin
    b. Factor VIII
    c. Alpha-2 Antiplasmin
    d. Antithrombin III
    e. Factor IX
    f. Von Willebrand's Factor
    g. Fibrinogen
    h. t-PA
  10. Blood Preservation
  11. Autologous Blood Transfusion/Freezing

III. FRANCE

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests

IV. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Molecular Blood Typing and Grouping
B. Infectious Disease Screening
C. Auxiliary

V. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts

VI. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection

VII. COMPETITIVE ASSESSMENTS

Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Hologic/Gen-Probe
Grifols
Immucor
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Quidel
Roche
Siemens
Tecan

LIST OF TABLES

Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
Executive Summary Table: France, Total Blood Bank Test Volume and Reagent Sales Forecast By Test Category
France, Facilities Performing Blood Bank Tests by Market Segment
France, Hospital Laboratories Performing Blood Bank Tests by Bed Size
France, Commercial/Private Laboratories Performing Blood Bank Tests By Annual Test Volume
France, All Market Segments Blood Typing And Grouping Test Volume Forecast by Market Segment
France, All Market Segments Blood Typing And Grouping Test Volume Forecast
France, Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
France, Blood Banks Blood Typing And Grouping Test Volume Forecast
France, Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
France, All Market Segments Infectious Disease Screening Test Volume Forecast By Market Segment
France, All Market Segments Infectious Disease Screening Test Volume Forecast
France, Blood Banks Infectious Disease Screening Test Volume Forecast
France, Commercial/Private Laboratories Infectious Disease Screening Test Volume Forecast
France, Hospital Laboratories Infectious Disease Screening Test Volume Forecast
France, All Market Segments Blood Typing And Grouping Reagent Market Forecast By Market Segment
France, All Market Segments Blood Typing And Grouping Reagent Market Forecast By Major Test
France, Hospital Laboratories Blood Typing and Grouping Reagent Market Forecast By Major
France, Blood Banks Blood Typing and Grouping Reagent Market Forecast by Major Test
France, Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast By Major Test
France, All Market Segments Infectious Disease Screening Reagent Market Forecast By Market Segment
France, All Market Segments Infectious Disease Screening Reagent Market Forecast By Test
France, Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
France, Commercial/Private Laboratories Infectious Disease Screening Reagent Market Forecast By Test
France, Hospital Laboratories Infectious Disease Screening Reagent Market Forecast by Test
France, Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And Market Shares
France, HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
France, Hepatitis Blood Screening Market, Reagent Sales by Major Supplier
France, HIV/Hepatitis NAT Screening Market Reagent Sales by Major Supplier
France, CMV Blood Screening Market, Reagent Sales By Major Supplier
France, Syphilis Blood Screening Market, Reagent Sales By Major Supplier


More Publications